MariMed Inc. (MRMD)
OTCMKTS · Delayed Price · Currency is USD
0.0869
+0.0000 (0.06%)
At close: Jan 30, 2026
MariMed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 157.38 | 157.96 | 148.6 | 134.01 | 121.46 | 50.9 | |
Revenue Growth (YoY) | -0.18% | 6.30% | 10.89% | 10.33% | 138.66% | 11.60% |
Cost of Revenue | 97.09 | 95.1 | 82.68 | 70.05 | 55.2 | 19.57 |
Gross Profit | 60.29 | 62.87 | 65.92 | 63.96 | 66.26 | 31.32 |
Selling, General & Admin | 57.89 | 59.34 | 50.72 | 38.88 | 37.54 | 15.81 |
Operating Expenses | 59.21 | 59.01 | 50.84 | 42.63 | 39.4 | 16.79 |
Operating Income | 1.08 | 3.86 | 15.08 | 21.33 | 26.86 | 14.53 |
Interest Expense | -7.24 | -6.94 | -9.19 | -1.69 | -2.36 | -9.81 |
Interest & Investment Income | 0.11 | 0.11 | 0.27 | 0.96 | 0.11 | 0.26 |
Other Non Operating Income (Expenses) | 0.31 | 0.11 | -0.65 | -0.05 | -0 | - |
EBT Excluding Unusual Items | -5.73 | -2.86 | 5.51 | 20.55 | 24.61 | 4.98 |
Merger & Restructuring Charges | -0.54 | -0.95 | -0.7 | -0.96 | - | - |
Gain (Loss) on Sale of Investments | - | -0.15 | -0.08 | -0.08 | -0.8 | -0.35 |
Gain (Loss) on Sale of Assets | -0.28 | -0.01 | -0.91 | - | - | - |
Asset Writedown | - | - | - | - | - | -0.08 |
Other Unusual Items | - | - | -10.43 | - | - | -0.04 |
Pretax Income | -6.55 | -3.97 | -6.6 | 19.51 | 23.82 | 4.5 |
Income Tax Expense | 11.23 | 8.16 | 9.41 | 5.89 | 16.19 | 2.07 |
Earnings From Continuing Operations | -17.78 | -12.13 | -16.01 | 13.61 | 7.62 | 2.43 |
Minority Interest in Earnings | -0.04 | -0.04 | -0.02 | -0.15 | -0.4 | -0.29 |
Net Income | -17.82 | -12.16 | -16.03 | 13.47 | 7.23 | 2.14 |
Net Income to Common | -17.82 | -12.16 | -16.03 | 13.47 | 7.23 | 2.14 |
Net Income Growth | - | - | - | 86.41% | 236.99% | - |
Shares Outstanding (Basic) | 387 | 379 | 363 | 338 | 326 | 267 |
Shares Outstanding (Diluted) | 387 | 379 | 363 | 380 | 372 | 324 |
Shares Change (YoY) | 2.31% | 4.33% | -4.44% | 2.12% | 14.88% | 55.31% |
EPS (Basic) | -0.05 | -0.03 | -0.04 | 0.04 | 0.02 | 0.01 |
EPS (Diluted) | -0.05 | -0.03 | -0.04 | 0.04 | 0.02 | 0.01 |
EPS Growth | - | - | - | 99.41% | 149.07% | - |
Free Cash Flow | 1.66 | -5.18 | -12.22 | -4.83 | 17.98 | -1.31 |
Free Cash Flow Per Share | 0.00 | -0.01 | -0.03 | -0.01 | 0.05 | -0.00 |
Gross Margin | 38.31% | 39.80% | 44.36% | 47.73% | 54.55% | 61.55% |
Operating Margin | 0.69% | 2.44% | 10.15% | 15.92% | 22.12% | 28.55% |
Profit Margin | -11.32% | -7.70% | -10.79% | 10.05% | 5.95% | 4.21% |
Free Cash Flow Margin | 1.05% | -3.28% | -8.22% | -3.60% | 14.80% | -2.57% |
EBITDA | 12.75 | 14.72 | 23.65 | 26.04 | 29.65 | 16.71 |
EBITDA Margin | 8.10% | 9.32% | 15.92% | 19.43% | 24.41% | 32.84% |
D&A For EBITDA | 11.67 | 10.86 | 8.57 | 4.71 | 2.79 | 2.18 |
EBIT | 1.08 | 3.86 | 15.08 | 21.33 | 26.86 | 14.53 |
EBIT Margin | 0.69% | 2.44% | 10.15% | 15.92% | 22.12% | 28.55% |
Effective Tax Rate | - | - | - | 30.21% | 67.99% | 45.97% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.